指南的实施能有效减少血液肿瘤科质子泵抑制剂的使用：降低风险的多学科干预措施。
Guideline implementation is effective at reducing proton pump inhibitor use in hematology-oncology units: A multidisciplinary intervention for reducing risk.
机构信息
Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Department of Pharmacy Services, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
出版信息
Infect Control Hosp Epidemiol. 2019 Nov;40(11):1294-1296. doi: 10.1017/ice.2019.238. Epub 2019 Aug 30.
Abstract
We implemented a guideline for appropriate acid suppressant use in hematology-oncology patients. This intervention resulted in a sustained reduction in proton pump inhibitor (PPI) use without an increase in rates of gastrointestinal bleeding. Practice guidelines are effective in reducing PPI use, which is associated with risk of Clostridioides difficile infection.
摘要
我们为血液肿瘤科患者实施了适当使用抑酸剂的指南。这一干预措施使得质子泵抑制剂（PPI）的使用持续减少，而胃肠道出血的发生率并未增加。实践指南在减少 PPI 使用方面是有效的，因为 PPI 使用与艰难梭菌感染的风险相关。
相似文献
1
Guideline implementation is effective at reducing proton pump inhibitor use in hematology-oncology units: A multidisciplinary intervention for reducing risk.指南的实施能有效减少血液肿瘤科质子泵抑制剂的使用：降低风险的多学科干预措施。
Infect Control Hosp Epidemiol. 2019 Nov;40(11):1294-1296. doi: 10.1017/ice.2019.238. Epub 2019 Aug 30.
2
Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal tract bleeding: effect of standardized guidelines on prescribing practice.质子泵抑制剂用于预防医院获得性上消化道出血：标准化指南对处方实践的影响。
Arch Intern Med. 2010 May 10;170(9):779-83. doi: 10.1001/archinternmed.2010.51.
3
Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.组胺 2 受体拮抗剂与质子泵抑制剂对重症监护病房胃肠道出血和感染并发症的影响。
JAMA Intern Med. 2014 Apr;174(4):564-74. doi: 10.1001/jamainternmed.2013.14673.
4
Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction.与心肌梗死后接受双联抗血小板治疗的患者相比，质子泵抑制剂治疗降低了胃肠道出血的风险。
Eur Heart J. 2019 Jun 21;40(24):1963-1970. doi: 10.1093/eurheartj/ehz104.
5
Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care: Current Practice as Reflected in a Large Administrative Database.儿科重症监护中胃酸抑制剂的预防性应用：大型管理数据库所反映的当前实践
Pediatr Crit Care Med. 2015 Sep;16(7):605-12. doi: 10.1097/PCC.0000000000000427.
6
Implementation of Global Strategies to Prevent Hospital-Onset Clostridium difficile Infection: Targeting Proton Pump Inhibitors and Probiotics.实施全球预防医院获得性艰难梭菌感染的策略：以质子泵抑制剂和益生菌为目标
Ann Pharmacother. 2017 Oct;51(10):848-854. doi: 10.1177/1060028017694050. Epub 2017 Aug 18.
7
Using a Systems Engineering Framework to Evaluate Proton Pump Inhibitor Prescribing in Critically Ill Patients.使用系统工程框架评估重症患者质子泵抑制剂的处方情况。
J Healthc Qual. 2020 Jul/Aug;42(4):e39-e49. doi: 10.1097/JHQ.0000000000000209.
8
A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol.一项关于质子泵抑制剂与组胺-2受体阻滞剂在重症监护病房预防溃疡治疗中的群组随机、交叉、注册嵌入临床试验（PEPTIC研究）：研究方案。
Crit Care Resusc. 2018 Sep;20(3):182-189.
9
Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis.评估使用质子泵抑制剂导致医院获得性艰难梭菌感染的风险：一项荟萃分析。
Infect Control Hosp Epidemiol. 2016 Dec;37(12):1408-1417. doi: 10.1017/ice.2016.194. Epub 2016 Sep 28.
10
Healthcare associated infection in adult surgical and medical patients hospitalized in tertiary hospital in Belgrade, Serbia: a seven years prospective cohort study.塞尔维亚贝尔格莱德一家三级医院成年外科和内科住院患者的医源性感染：一项为期七年的前瞻性队列研究。
Libyan J Med. 2020 Dec;15(1):1708639. doi: 10.1080/19932820.2019.1708639.
引用本文的文献
1
infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options.感染：历史、流行病学、风险因素、预防、临床表现、治疗和未来选择。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0013523. doi: 10.1128/cmr.00135-23. Epub 2024 Feb 29.
2
Impact of pharmacy-supported interventions on proportion of patients receiving non-indicated acid suppressive therapy upon discharge: A systematic review and meta-analysis.药学支持干预对出院时接受非指征性抑酸治疗患者比例的影响：系统评价和荟萃分析。
PLoS One. 2020 Dec 3;15(12):e0243134. doi: 10.1371/journal.pone.0243134. eCollection 2020.
3
"Get Me Off This Medication!": A Comparison Between Gastroenterology and Primary Care Regarding Patient's Perceptions of Proton Pump Inhibitor Therapy.“让我停用这种药物！”：胃肠病学与初级保健在患者对质子泵抑制剂治疗认知方面的比较
Cureus. 2020 Oct 25;12(10):e11158. doi: 10.7759/cureus.11158.
本文引用的文献
1
Clostridium difficile in Immunocompromised Hosts: A Review of Epidemiology, Risk Factors, Treatment, and Prevention.免疫功能低下宿主中的艰难梭菌：流行病学、危险因素、治疗和预防的综述。
Clin Infect Dis. 2019 May 30;68(12):2144-2153. doi: 10.1093/cid/ciy845.
2
Clinical Characteristics and Outcomes of Hematologic Malignancy Patients With Positive Clostridium difficile Toxin Immunoassay Versus Polymerase Chain Reaction Test Results.艰难梭菌毒素免疫检测阳性与聚合酶链反应检测结果阳性的血液系统恶性肿瘤患者的临床特征和结局。
Infect Control Hosp Epidemiol. 2018 Jul;39(7):863-866. doi: 10.1017/ice.2018.83. Epub 2018 Apr 25.
3
Outcomes From a Pharmacist - led Proton Pump Inhibitor Stewardship Program at a Single Institution.单机构药师主导的质子泵抑制剂管理项目的结果
Hosp Pharm. 2018 Feb;53(1):59-67. doi: 10.1177/0018578717747192. Epub 2017 Dec 13.
4
Proton Pump Inhibitors in cancer patients: How useful they are? A review of the most common indications for their use.质子泵抑制剂在癌症患者中的应用：它们有何作用？对其常见适应证的综述。
Crit Rev Oncol Hematol. 2017 Mar;111:144-151. doi: 10.1016/j.critrevonc.2017.01.014. Epub 2017 Feb 3.
5
Reducing co-administration of proton pump inhibitors and antibiotics using a computerized order entry alert and prospective audit and feedback.使用计算机化医嘱录入警报以及前瞻性审核与反馈来减少质子泵抑制剂和抗生素的联合使用。
BMC Infect Dis. 2016 Jul 22;16:355. doi: 10.1186/s12879-016-1679-8.
6
Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.组胺 2 受体拮抗剂与质子泵抑制剂对重症监护病房胃肠道出血和感染并发症的影响。
JAMA Intern Med. 2014 Apr;174(4):564-74. doi: 10.1001/jamainternmed.2013.14673.
7
Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis.艰难梭菌相关性腹泻与质子泵抑制剂治疗：一项荟萃分析。
Am J Gastroenterol. 2012 Jul;107(7):1001-10. doi: 10.1038/ajg.2012.179. Epub 2012 Jun 19.
8
Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.抑酸药物和抗生素与艰难梭菌感染风险：荟萃分析。
Am J Gastroenterol. 2012 Jul;107(7):1011-9. doi: 10.1038/ajg.2012.108. Epub 2012 Apr 24.
9
Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.使用胃酸抑制剂与社区获得性艰难梭菌相关疾病的风险
JAMA. 2005 Dec 21;294(23):2989-95. doi: 10.1001/jama.294.23.2989.
10
Randomized trial of omeprazole or ranitidine versus placebo in the prevention of chemotherapy-induced gastroduodenal injury.奥美拉唑或雷尼替丁与安慰剂预防化疗引起的胃十二指肠损伤的随机试验。
J Clin Oncol. 2000 Feb;18(3):463-7. doi: 10.1200/JCO.2000.18.3.463.
Zotero 插件